You can buy now, pay later for weight-loss drugs: Here's what you need to know [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by telehealth provider FuturHealth and consumer finance company Affirm. FuturHealth CEO Luke Mahoney said the partnership gives customers one more option to access the popular glucagon-like peptide-1, or GLP-1, weight-loss drugs. Consumers are struggling to afford brand-name GLP-1 drugs , and the less expensive compounded versions are expected to soon be phased out. "The pricing has kept the branded meds out of reach for a lot of people," said Mahoney. The financing option comes as consumers who've used less expensive compounded versions of t
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at Dbs Bank to a "sell" rating.MarketBeat
- Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- CFO of SAP, Europe's most valuable company, hopes trade war is a ‘wake-up call' for the continent [Yahoo! Finance]Yahoo! Finance
- CFO of SAP, Europe's most valuable company, hopes trade war is a ‘wake-up call' for the continent [Fortune]Fortune
- West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies [Yahoo! Finance Canada]Yahoo! Finance Canada
NVO
Earnings
- 2/6/25 - Beat
NVO
Sec Filings
- 4/23/25 - Form SCHEDULE
- 4/3/25 - Form 6-K
- 3/31/25 - Form 6-K
- NVO's page on the SEC website